SCHEMBL23861636

SCHEMBL23861636

CC(c1c(O)cc(O)cc1O)(c1c(O)ccc2ccccc12)c1c(O)ccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.47
▸ PTPN22 Q9Y2R2 1/20 0.44
▸ POLB P06746 2/20 0.42
▸ CYP1A2 P05177 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ PAK1 Q13153 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ MAPT P10636 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ GAA P10253 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.39
▸ ERN1 O75460 1/20 0.39
▸ HCRTR1 O43613 1/20 0.38
▸ HSP90AA1 P07900 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861513 0.85 LMNA (0.40) CYP2C9HSD17B10KDM4ETDP1GAA
SCHEMBL23861635 0.83 ESR1 (0.39) NQO2CYP1A2CYP2C9CYP2C19HSD17B10
SCHEMBL23861563 0.81 PTPN22 (0.48) PTPN22POLBCYP1A2USP2PAK1
SCHEMBL23861443 0.79 ESR1 (0.47) PTPN22POLBCYP1A2USP2PAK1
SCHEMBL23861638 0.79 POLB (0.44) PTPN22POLBCYP1A2USP2PAK1
SCHEMBL31356444 0.78 PTPN22 (0.54) PTPN22POLBCYP1A2USP2PAK1
SCHEMBL20398800 0.78 PTPN22 (0.54) PTPN22POLBCYP1A2USP2PAK1
SCHEMBL2221239 0.78 PTPN22 (0.54) PTPN22POLBCYP1A2USP2PAK1
SCHEMBL23499948 0.77 PTPN22 (0.52) PTPN22POLBCYP1A2USP2PAK1
SCHEMBL23861600 0.77 PTPN22 (0.53) PTPN22POLBCYP1A2USP2PAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 NQO2 1113/4885PTPN22 2079/4885POLB 1919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback